P-aminosalicylic acid
Pharmaceutical forms
Tablet
Country lists
ATC N/A
Composition 500 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • Others observations:
    Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.  
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • No observations
Granules
Country lists
ATC N/A
Composition 4 g in sachet
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • Others observations:
    Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.  
Bolivia
LINAME 2011 - 2013
  • No observations
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • No observations